FTC v. Actavis: Post Argument Discussion

Mar 25, 2013 | Room 602 Event: 4:00 | Reception: 5:30 American University Washington College of Law 4801 Massachusetts Ave NW Washington DC, 20016 (map)

 

UPDATE: Supreme Court Ruling, June 2013

In PIJIP’s ongoing Supreme Court series, counsel for parties and amici will discuss intellectual property cases on the afternoon of oral argument, addressing the reaction of the Court at oral argument.  In this case the Supreme Court examines whether reverse-payment agreements are per se lawful unless the underlying patent litigation was a sham or the patent was obtained by fraud (as the court below held), or instead are presumptively anticompetitive and unlawful (as the Third Circuit has held).  Reverse payment agreements are a type of settlement agreement where brand-name drug manufacturers pay potential generic competitors to agree not to sell competing generic drugs for a period of years.

• Michael Carroll – Washington College of Law, Moderator
• Julia York – Skadden, Arps, Slate, Meagher & Flom LLP, counsel for Respondent, Actavis, Inc.
• Rohit Singla– Munger, Tolles & Olson LLP, counsel for Respondent, Solvay Pharmaceuticals, Inc.
• Ryan Christian – White & Case LLP, counsel for Respondent, Par Pharmaceutical Companies, Inc.
• Krista Cox – Knowledge Ecology International, counsel for amicus Knowledge Ecology International, supporting Petitioner
• Scott Hemphill – Columbia Law School

Oral Argument

• Transcript

Briefs

• Brief for Petitioner (FTC)
• Brief for Respondent (Par Pharmaceutical)
• Brief for Respondent (Actavis)
• Brief for Respondent (Solvay Pharmaceuticals)

Amicus Briefs

• Knowledge Ecology International Amicus Brief
• Public Patent Foundation Amicus Brief
• Louisiana Wholesale PUrschasers Amicus Brief
• America’s Health Insurance Plans Amicus Brief
• New York, et al. Amicus Brief
• 118 Law, Economics, and Business Professors Amicus Brief
• Apotex Amicus Brief
• AARP Amicus Brief
• Representative Henry A. Waxman Amicus Brief
• National Association of Chain Drug Stores Amicus Brief

• National Association of Manufacturers Amicus Brief
• Generic Manufacturers Amicus Brief
• Enavail Amicus Brief
• Generic Pharmaceutical Association Amicus Brief
• Bayer Amicus Brief
• Shire PLC Amicus Brief
• NYIPLA Amicus Brief
• Merck Amicus Brief
• Pharmaceutical Research and Manufacturers of America Amicus Brief
• Antitrust Economists Amicus Brief
• Law Professors Gregory Dolin, Kent Bernard, et al. Amicus Brief
• AIPLA Amicus Brief
• Mediation and Negotiation Professionals Amicus Brief
• David Opderbeck and Erik Lillquist Amicus Brief
• Health, Economics, and Law Professors Amicus Brief
• Washington Legal Foundation Amicus Brief
• Intellectual Property Owners Association Amicus Brief